Sue Darcey
Senior reporter
Washington DC, USA
15+ years of experience
A Washington DC-based trade journalist with over 30 years' experience covering Capitol Hill and regulatory agencies including FDA, CMS and the EPA, Sue is constantly on the look-out for any new laws, regulations, challenging device and test makers, and ways that firms resolve those issues. She also writes extensively about CMS changes to paying providers for their value-based practices, rather than on a fee-for-service basis, and how the changes affect device reimbursements.
When Sue is not covering the US Congress, CMS, and the medtech industry, she likes to be outdoors, where she can be found birding, hiking, gardening, swimming, and taking photos of flora and fauna of the US mid-Atlantic region.
Sue Darcey 27 Nov 2020
Bioresearchers at the Centers for Disease Control and Prevention are hoping that diagnostic platforms previously used to develop tests for outbreaks of other epidemic respiratory diseases, including SARS and MERS, can be built on to develop new diagnostics to detect more cases in the current coronavirus outbreak, US infectious disease authorities say. This comes as more patients are monitored around the US for the disease, and a Chicago woman returning from China tests positive.
Sue Darcey 12 Mar 2020
An $8.3bn “Coronavirus Preparedness and Response Supplemental” funding act approved by the US Congress last week and signed into law on 6 March provides dollars and lays out the roles federal agencies, such as the FDA, and state and local agencies must play in containing and controlling the spread of COVID-19.
12 Jan 2021
15 Dec 2020
11 Dec 2020
23 Nov 2020
Medtech Insight
20 Nov 2020
18 Nov 2020
02 Nov 2020
28 Oct 2020
Medtech Insight
21 Aug 2020
12 Aug 2020
06 Aug 2020
29 Jul 2020
01 Jul 2020
15 Jun 2020
Medtech Insight
27 Apr 2020